Fosun Returns Leaner With An Attractive Valuation

Core Viewpoint - Fosun International Ltd. is continuing its strategy of divestment to improve its capital structure and liquidity, as evidenced by the sale of 40% of its Luz Saúde healthcare group for 310 million euros ($364 million) while retaining a 60% stake in the company [2][3][4] Group 1: Strategic Benefits of the Sale - The sale of Luz Saúde is expected to enhance the company's capital structure and liquidity, facilitate business growth through collaboration with a strategic partner, and strengthen the shareholder base for mid-term expansion [3] - Luz Saúde operates 29 medical facilities in Portugal, serving 75% of the population, indicating its significant market presence [4] Group 2: Ongoing Investment Strategy - Fosun's divestment strategy is not a retreat from Portugal but rather a method to maintain market exposure while improving debt metrics and generating capital for further investments [6][9] - The company has previously sold stakes in other investments, such as 5.6% of Banco Comercial Português for 235 million euros and two towers in Lisbon for 192 million euros, while retaining control over these assets [5] Group 3: Financial Recovery and Debt Management - Fosun's total debt was reported at 222.1 billion yuan ($31 billion) as of June, with a slight increase from the previous year, while holding 67.8 billion yuan in cash and bank balances [10] - The company has been actively deleveraging since mid-2022, selling various assets to stabilize its finances and improve funding access [12] - Following its recovery, Fosun returned to the U.S. dollar bond market, issuing $300 million in notes, which was viewed positively by S&P, affirming its credit rating with a stable outlook [13][14]